Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine
Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine
The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.
Inclusion Criteria:
Exclusion Criteria:
Other inclusion and exclusion criteria may apply.
HQ_Medinfo@Lundbeck.com+45 36301311
Stamford, Connecticut 06905, United States
Atlanta, Georgia 30328-5574, United States
Lexington, Kentucky 40508-1683, United States
Charlotte, North Carolina 28211-5027, United States
Cincinnati, Ohio 45229-3026, United States
San Miguel de Tucumán, Tucumán Province T4000AXL, Argentina
Penticton, British Columbia V2A 5L5, Canada
Victoria, British Columbia V8R 1J8, Canada
Pavia, Lombardy 27100, Italy
Cagliari, Sardinia 09121, Italy
Pavia, Tuscany 27100, Italy
Pisa, 56126, Italy
Morelia, Michoacán 58260, Mexico
Krakow, Lesser Poland Voivodeship 30-363, Poland
Oświęcim, Lesser Poland Voivodeship 32-600, Poland
Warszawa, Lower Silesian Voivodeship 02-677, Poland
Porto Covo, Setúbal District 4050-651, Portugal
Valencia, 46026, Spain
Eskişehir, 26480, Turkey (Türkiye)
Fatih/Istanbul, 34093, Turkey (Türkiye)
Edinburgh, Midlothian EH16 4TJ, United Kingdom
Great Yarmouth, Norfolk NR31 6LA, United Kingdom